98%
921
2 minutes
20
Collectin-11 (CL-11) is a multifunctional lectin that binds carbohydrates on pathogens and inhibits infection through direct neutralization, agglutination, opsonization and killing pathogens, playing an important role in innate immunity. In the present study, a homolog of collectin-11 (CL-11), designated as CcCL-11, was identified and functionally characterized from Yellow River carp (Cyprinus carpio haematopterus). Its expression profile and agglutination activity were systematically analyzed. The full-length cDNA of CcCL-11 was 834 bp and it contained an open reading frame (ORF) of 831 bp that encoded 277 amino acids. The amino acid sequence of CcCL-11 contains signal peptide, collagen-like region (CLR), α-helical neck region and carbohydrate recognition domain (CRD). Tissue expression profiling analysis showed that CcCL-11 was ubiquitously distributed in the tested tissues and was highly expressed in the liver. Furthermore, CcCL-11 expression was significantly upregulated in the liver and intestine after challenge with a Gram-positive bacterial pathogen (Staphylococcus aureus) and a Gram-negative bacterial pathogen (Aeromonas hydrophila). The recombinant CcCL-11 (rCcCL-11) is able to agglutinate and bind to Aeromonas hydrophila, Aeromonas veronii, Escherichia coli, Klebsiella pneumoniae, Micrococcus lysodeikticus, Bacillus subtilis and Staphylococcus aureus and it possessed haemagglutination activity against C. carpio erythrocytes. In addition, rCcCL-11 showed concentration-dependent binding to major bacterial cell wall components such as lipopolysaccharide (LPS) and peptidoglycan (PGN). Competition ELISA analysis showed that certain concentrations of carbohydrates can inhibit the binding of rCcCL-11 to bacteria. These findings confirm the biological activity of CcCL-11 and suggest that it plays an important role in pattern recognition. In vivo experiments demonstrated that rCcCL-11 could promote the clearance of A. hydrophila in the liver, kidney, and spleen of C. carpio, and enhance the survival rate of the fish. In summary, the results of this study indicate that CcCL-11 has obvious agglutination and binding effects on pathogenic bacteria and may serve as a pattern recognition receptor (PRR) to participate in the natural immune response of C. carpio against bacterial infection.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.fsi.2025.110572 | DOI Listing |
Mol Ther
September 2025
Department of Medicine, UMass Chan Medical School, Worcester, MA, USA; Department of Genetic and Cellular Medicine, UMass Chan Medical School, Worcester, MA, USA; Horae Gene Therapy Center, UMass Chan Medical School, Worcester, MA, USA; Li Weibo Institute for Rare Diseases Research, UMass Chan Medic
The interleukin (IL)-1 pathway is a key mediator of inflammation and innate immune responses. Its dysregulation contributes to rheumatoid arthritis (RA) and autoinflammatory diseases (AIDs). In this study, we develop a recombinant adeno-associated virus (rAAV)-based gene therapy to deliver an inflammation-inducible, secreted human IL-1 receptor antagonist (sIL-1Ra) as a complementary approach to existing IL-1 blockers.
View Article and Find Full Text PDFBackground: Devoid of a lymphatic system, the central nervous system (CNS) relies primarily on innate immunity for protection. While these immune responses help to fight pathogens, they can also cause irreversible damage because of the CNS's limited regenerative capacity. Therefore, it is crucial to understand which CNS cells contribute to pathogen clearance but in doing so potentially damage surrounding tissue.
View Article and Find Full Text PDFInfluenza Other Respir Viruses
September 2025
Department of Respiratory, Children's Hospital of Nanjing Medical University, Nanjing, China.
Respiratory syncytial virus (RSV) is one of the leading causes of severe respiratory diseases in children, especially in infants. The immune responses induced by RSV infection are a fairly complex process that can contribute significantly to disease severity. Despite decades of research on RSV, many immune mechanisms remain to be explored.
View Article and Find Full Text PDFAAPS J
September 2025
Gene Transfer and Immunogenicity Branch, Division of Gene Therapy 2, Office of Gene Therapy, Office of Therapeutic Products, Center for Biologics Evaluation and Research, US Food and Drug Administration, WO52 RM3124, 10903 New Hampshire Ave, Silver Spring, Maryland, 20993-0002, USA.
As the field of gene therapy advances and as the importance of sex as a biological variable in shaping viral immune responses is recognized, the impact of sex on adeno-associated virus (AAV) vectors mediated gene therapies remain largely unexplored. Here we review current understanding of the immune response against AAV gene therapy as well as the knowledge of sex differences observed in viral responses. We discuss sex differences in innate immune mechanisms such as Toll-like receptor recognition and complement activation, as well as the functional responses of key immune cells such as dendritic cells, macrophages, and T/B cells that are involved in AAV immunogenicity.
View Article and Find Full Text PDFEMBO J
September 2025
Department of Bacterial Infection and Host Response, Graduate School of Medical and Dental Sciences, Institute of SCIENCE TOKYO, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8510, Japan.
Many enteric bacterial pathogens deliver virulence effectors to counteract host innate immune responses, such as inflammation and cell death, and colonize the intestinal epithelium. However, host cells recognize the disruption of their innate immune signaling by bacterial effectors and induce alternative immune responses, collectively termed "effector-triggered immunity", to clear bacterial pathogens. Here, we describe a mechanism of cell death induction via effector-triggered immunity and the bacterial countermeasures of the pathogen Shigella flexneri.
View Article and Find Full Text PDF